Blog - Page 864 of 5697 - QualityStocks

MondayOct 10, 2022 1:35 pm

QualityStocksNewsBreaks – Why HeartBeam Inc. (NASDAQ: BEAT) Is ‘One to Watch’

HeartBeam (NASDAQ: BEAT) is a cardiac technology company whose initial focus is on providing diagnostic data through its 3D-vector 12-lead electrocardiogram (“ECG”) platform – the first and only to be developed – for heart attack detection anytime, anywhere. Its development portfolio includes HeartBeam AIMI(TM), a software that provides a 3D comparison of baseline and symptomatic 12-lead ECG to more accurately and speedily identify a heart attack in acute care settings. Also under development is HeartBeam AIMIGo(TM), the first and only credit card-sized 12-lead output ECG device for remote heart attack detection that combines a smartphone app and cloud-based diagnostic software…

MondayOct 10, 2022 12:04 pm

QualityStocksNewsBreaks – Advanced Container Technologies Inc. (ACTX) Offers Year-Round Farming Option, Higher-Nutrient Crops

Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of self-contained, automated, indoor “micro-farms” called GrowPods, provides a new income opportunity for farmers. The company’s GrowPods, or unique controlled environment farms, offer the ideal environment for farmers to grow crops all year long; as an added advantage, the crops are high nutrient, clean and sustainable. According to the announcement, recent reports have highlighted the challenges that farmers face, including increasing debt, extreme weather conditions, consolidation, degrading and eroding soils, and increased pesticide and chemical use that impact the nutrient value of harvests. One study noted that farmers are among the…

MondayOct 10, 2022 12:00 pm

REZYFi, Inc. Leverages Rapidly Growing Cannabis Industry, Offering Needed Mortgage and Lending Solutions

REZYFi is a specialized financing company in the U.S., originating, structuring, and investing in first mortgage loans and alternative structured financings secured by commercial real estate properties Target markets include licensed and permitted cannabis companies, owners of real estate who lease to cannabis companies, and companies and individual homeowners seeking a variety of real estate-related first and additional mortgage-based financing Currently licensed in 36 states, with plans for expansion into all states, REZYFi is leveraging its experience, a network of independent brokers, and proprietary technology, to enhance its offering within target markets REZYFi operates through two wholly-owned subsidiaries – REZYFi…

MondayOct 10, 2022 11:57 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Participate in Breakthrough for Brain Tumors(R) 5K Run

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that its Chief Executive Officer John Climaco will participate in The American Brain Tumor Association’s Breakthrough for Brain Tumors(R) 5K Run. The event is taking place on Saturday, Nov. 5, 2022, in Los Angeles, California. “The unmet need in brain tumor treatment is immense and knows no geographic borders. As CEO of CNS, I have come to know many brain tumor patients personally and the optimism and strength with which they have…

MondayOct 10, 2022 11:15 am

Rosy Outlook for Global Cannabis Market Boosts Hopes for Flora Growth Corp. (NASDAQ: FLGC) as Supply Chain Expands

Cannabis grower and product maker Flora Growth is developing its own approach to riding troubling economic forces, boasting a 604 percent YOY increase in the H1 reporting period this year Market analysts predict the global cannabis market’s value will rise during the next five years at a CAGR of 24.3 percent to arrive at annual valuation of $82.3 billion Flora Growth is levying the potential of recent cooperative agreements to increase the reach of its product distribution pipeline, including new exports to Switzerland, the Czech Republic and the United States Europe is predicted to be the fastest-growing region for cannabis…

MondayOct 10, 2022 10:34 am

QualityStocksNewsBreaks – Iconic Brands Inc. (ICNB) to Participate at Dawson James Small Cap Growth Conference

Iconic Brands (OTCQB: ICNB), a leader in the development, design and delivery of alcohol and nonalcohol beverages, will be a featured company at the 7th annual Dawson James Small Cap Growth Conference. The company announced that Iconic interim CEO and TopPop founder and CEO Thomas Martin will be presenting at the one-day conference, which is scheduled for Oct. 12, 2022. The in-person conference will be held in Jupiter, Florida. Martin’s presentation will include an overview of the company as well as significant milestones and upcoming strategic developments; the time of the presentation is forthcoming. Martin will also be available during…

MondayOct 10, 2022 10:30 am

Reklaim Ltd. (TSX.V: MYID) (OTCQB: MYIDF) Poised for Growth Amid Changing Data-Privacy Environment; Seeks to Bridge the Gap Between Consumers and Their Data

Reklaim appears poised to capitalize on new market opportunities for companies with a competitive edge in compliant data; it seeks to position itself as the go-to privacy-compliant data partner Shifting data-protection regulations and stricter privacy policies of Big Tech companies like Apple and Google require brands to replace their existing data suppliers with those compliant with new privacy standards Reklaim’s platform allows consumers to claim control of their personal data while brands can buy and sell consumer-consented privacy-compliant data As the era of online tracking and monetizing consumer data without explicit consent is coming to an end, companies like Reklaim…

MondayOct 10, 2022 10:25 am

QualityStocksNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Initiates Safety Evaluation Study of Its Novel Time-Released Ketamine Formulation

Silo Pharma (NASDAQ: SILO) is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research. The company today announced that it has initiated a preclinical toxicity study of its novel time-released, dosage controlled formulation of ketamine, designated as SP-26, for the treatment of fibromyalgia. “We are working closely with our joint venture partner Zylö Therapeutics in developing a topical sustained released ketamine utilizing Z-pod(TM) technology,” said Eric Weisblum, CEO of Silo Pharma. “Preclinical studies have already shown that our joint developed delivery method and formulation can hold and distribute ketamine in a time-released manner. SP-26 reported positive…

MondayOct 10, 2022 9:45 am

As Carbon Dioxide Concentrations Set Records, EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Delivers RNG Solutions for Environmental Consciousness

CO2 concentrations in the atmosphere are at the highest of the modern record era EverGen develops and operates renewable natural gas projects that significantly reduce pollutants like CO2 and methane With major customers and partners, EverGen has expanded from a single facility in British Columbia to a series of projects across Canada Natural gas prices are soaring around the world, partly contributing to the inflation in Europe that has risen to a record 10% in September. At the same time, citizens in New Jersey gripe over state regulators approving natural gas rate hikes that went into effect Saturday ahead of…

MondayOct 10, 2022 9:00 am

Odyssey Health, Inc. (ODYY) PRV-002 Compound Takes on Heightened Significance Following Recent Concussion of Dolphins Quarterback Tua Tagovailoa, and the NFL and NFLPA’s Announcement on Changes to Concussion Protocol

The concussion controversy surrounding Tua Tagovailoa has prompted both the NFL and the NFLPA to revisit the league’s concussion protocol in a move designed to enhance player safety In the wake of this controversy, Odyssey is emphasizing the potential value of its PRV-002 novel compound for the treatment of concussions and the benefit of the players According to a report published by Vox, there are approximately 0.41 concussions per NFL game in American football, with 9.3% of concussions involving the loss of consciousness and 2.4% resulting in hospitalizations With such cases, there is a need to revise the NFL’s concussion…

Site Search

Company Search